» Articles » PMID: 37770480

Metabolic Crosstalk Between Skeletal Muscle Cells and Liver Through IRF4-FSTL1 in Nonalcoholic Steatohepatitis

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Sep 28
PMID 37770480
Authors
Affiliations
Soon will be listed here.
Abstract

Inter-organ crosstalk has gained increasing attention in recent times; however, the underlying mechanisms remain unclear. In this study, we elucidate an endocrine pathway that is regulated by skeletal muscle interferon regulatory factor (IRF) 4, which manipulates liver pathology. Skeletal muscle specific IRF4 knockout (F4MKO) mice exhibited ameliorated hepatic steatosis, inflammation, and fibrosis, without changes in body weight, when put on a nonalcoholic steatohepatitis (NASH) diet. Proteomics analysis results suggested that follistatin-like protein 1 (FSTL1) may constitute a link between muscles and the liver. Dual luciferase assays showed that IRF4 can transcriptionally regulate FSTL1. Further, inducing FSTL1 expression in the muscles of F4MKO mice is sufficient to restore liver pathology. In addition, co-culture experiments confirmed that FSTL1 plays a distinct role in various liver cell types via different receptors. Finally, we observed that the serum FSTL1 level is positively correlated with NASH progression in humans. These data indicate a signaling pathway involving IRF4-FSTL1-DIP2A/CD14, that links skeletal muscle cells to the liver in the pathogenesis of NASH.

Citing Articles

Extracellular vesicle-mediated bidirectional communication between the liver and other organs: mechanistic exploration and prospects for clinical applications.

Mo W, Peng Y, Zheng Y, Zhao S, Deng L, Fan X J Nanobiotechnology. 2025; 23(1):190.

PMID: 40055724 PMC: 11889855. DOI: 10.1186/s12951-025-03259-4.


FSTL1 accelerates nucleus pulposus-derived mesenchymal stem cell apoptosis in intervertebral disc degeneration by activating TGF-β-mediated Smad2/3 phosphorylation.

Yan X, Ding J, Zhang R, Wang Y, Zhou L, Zhang H J Transl Med. 2025; 23(1):232.

PMID: 40011941 PMC: 11863476. DOI: 10.1186/s12967-025-06231-w.


Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease.

Fan Y, Zhang S, Wang Y, Wang H, Li H, Bai L Front Endocrinol (Lausanne). 2025; 15():1494560.

PMID: 39850476 PMC: 11754069. DOI: 10.3389/fendo.2024.1494560.


Integrative 3D genomics with multi-omics analysis and functional validation of genetic regulatory mechanisms of abdominal fat deposition in chickens.

Shen L, Bai X, Zhao L, Zhou J, Chang C, Li X Nat Commun. 2024; 15(1):9274.

PMID: 39468045 PMC: 11519623. DOI: 10.1038/s41467-024-53692-6.


Rodent model of metabolic dysfunction-associated fatty liver disease: a systematic review.

Cui X, Li H, Li L, Xie C, Gao J, Chen Y J Gastroenterol Hepatol. 2024; 40(1):48-66.

PMID: 39322221 PMC: 11771679. DOI: 10.1111/jgh.16749.


References
1.
Mattiotti A, Prakash S, Barnett P, van den Hoff M . Follistatin-like 1 in development and human diseases. Cell Mol Life Sci. 2018; 75(13):2339-2354. PMC: 5986856. DOI: 10.1007/s00018-018-2805-0. View

2.
Bedossa P . Pathology of non-alcoholic fatty liver disease. Liver Int. 2017; 37 Suppl 1:85-89. DOI: 10.1111/liv.13301. View

3.
Guo S, Huang Y, Zhang Y, Huang H, Hong S, Liu T . Impacts of exercise interventions on different diseases and organ functions in mice. J Sport Health Sci. 2020; 9(1):53-73. PMC: 6943779. DOI: 10.1016/j.jshs.2019.07.004. View

4.
Choi K, Jang H, Ahn J, Hwang S, Chung J, Choi Y . The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma. Clin Mol Hepatol. 2020; 26(4):492-505. PMC: 7641544. DOI: 10.3350/cmh.2020.0005. View

5.
Suppli M, Rigbolt K, Veidal S, Heeboll S, Eriksen P, Demant M . Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am J Physiol Gastrointest Liver Physiol. 2019; 316(4):G462-G472. DOI: 10.1152/ajpgi.00358.2018. View